KOBIE BENHAM: Open Payments
NPI 1457982506 · SNYDER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$123 in 6 payments from 4 companies in 2025. Trend: 2023 $134 · 2024 $322 · 2025 $123
Food & beverage: $123
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Novo Nordisk Inc | 2 | $39 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
Products named: FARXIGA, Ozempic, TRELEGY ELLIPTA, CAPLYTA.
Industry payments across TX — which companies pay providers there.
